Previous close | 0.6500 |
Open | 0.6500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 18.00 |
Expiry date | 2024-07-19 |
Day's range | 0.6500 - 0.6500 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Food and Drug Administration (FDA) has completed its comprehensive, multi-year review of Bovaer® (3-NOP), a first-in-class methane-reducing feed ingredient, and determined the product meets safety and efficacy requirements for use in lactating dairy cattle.
On May 21, 2024, Director William Doyle purchased 15,000 shares of Elanco Animal Health Inc (NYSE:ELAN) at a price of $16.98 per share, as reported in the SEC Filing.
Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Stifel 2024 Jaws and Paws Conference on Wednesday, May 29, 2024. Todd Young, executive vice president and CFO, will participate in a fireside chat at 8:00 a.m. ET.